Drug Profile
Research programme: growth hormone-releasing hormone agonists - Biscayne Pharmaceuticals
Alternative Names: BIS-5409; GHRH agonists - Biscayne; MR-409Latest Information Update: 21 Mar 2023
Price :
$50
*
At a glance
- Originator University of Miami
- Developer Biscayne Pharmaceuticals
- Class Hypothalamic hormones
- Mechanism of Action Growth hormone releasing factor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Myocardial infarction; Type 1 diabetes mellitus
Most Recent Events
- 21 Mar 2023 Discontinued - Preclinical for Myocardial infarction in USA (Parenteral)
- 21 Mar 2023 Discontinued - Preclinical for Type 1 diabetes mellitus in USA (unspecified route)
- 28 Nov 2019 No recent reports of development identified for preclinical development in Type-1 diabetes mellitus in USA